Risk factors for the development of ILD in patients with SSc include male sex, diffuse cutaneous SSc (dcSSc), African-American race, and the presence of certain autoantibodies such as anti-topoisomerase I (ATA), anti-Th/To, and anti-U3 RNP [5, 6]. The gene discussed is ATM; the disease is interstitial lung disease.